key: cord-1011147-54i3m36l
authors: García‐Arroyo, Laura; Prim, Núria; Martí, Neus; Roig, Maria Carme; Navarro, Ferran; Rabella, Núria
title: Benefits and drawbacks of molecular techniques for diagnosis of viral respiratory infections. Experience with two multiplex PCR assays
date: 2015-07-28
journal: J Med Virol
DOI: 10.1002/jmv.24298
sha: 7e60ffb809cefe49d47ded66e33e3970ce76bb65
doc_id: 1011147
cord_uid: 54i3m36l

Molecular techniques have represented a major step forward in the diagnosis of viral respiratory infections. They are considered highly sensitive and specific compared to conventional techniques. In this study two nucleic acid amplification tests (NAATs) were compared to conventional methods (immunofluorescence and viral culture). The aim of this work was to discuss the clinical interpretation of the results obtained by NAATs on the basis of the two‐decade experience of our group and the literature. Eighty nasopharyngeal aspirates were collected from children under six years attended for acute respiratory illness at the pediatric emergency room of a third level Hospital. Both NAATs tested (Seeplex(®) and Clart(®)) showed an overall higher performance regarding sensitivity (76% and 90%, respectively). Compared to Seeplex(®), the Clart(®) system tripled the number of multiple detections (8 by Seeplex(®) vs. 25 by Clart(®)). In some specimens both NAATs detected different viruses. Given these discrepancies and the fact that detection of viral nucleic acids is not necessarily related to the current clinical syndrome, the interpretation of molecular results may not always be so straightforward. The pros and cons of NAATs should always be taken into account when giving a result. J. Med. Virol. 88:45–50, 2016. © 2015 Wiley Periodicals, Inc.

Molecular techniques have represented a major step forward in the diagnosis of viral respiratory infections. They are considered highly sensitive and specific compared to conventional techniques. In this study two nucleic acid amplification tests (NAATs) were compared to conventional methods (immunofluorescence and viral culture). The aim of this work was to discuss the clinical interpretation of the results obtained by NAATs on the basis of the two-decade experience of our group and the literature. Eighty nasopharyngeal aspirates were collected from children under six years attended for acute respiratory illness at the pediatric emergency room of a third level Hospital. Both NAATs tested (Seeplex 1 and Clart 1 ) showed an overall higher performance regarding sensitivity (76% and 90%, respectively). Compared to Seeplex 1 , the Clart 1 system tripled the number of multiple detections (8 by Seeplex

Respiratory tract infections are the most frequent cause of illness in children, and most of them are of viral etiology [van de Pol et al., 2007; Mahony, 2008; Raymond et al., 2009; Vallieres and Renaud, 2013] . The most common respiratory viruses are Influenza A virus (FLUAV), Influenza B virus (FLUBV), Human parainfluenzavirus 1-4 (PIV-1-4), Human respiratory syncitial virus (RSV), Human metapneumovirus (hMPV), Enteroviruses (EV), Rhinoviruses (RV), Human coronaviruses (HCoV), Human bocaviruses (HBoV), and Human adenoviruses (AdV). As infections caused by respiratory viruses show similar clinical manifestations, microbiological studies must be performed to identify the etiology [Caliendo, 2011; Pagarolas and Sune, 2014] .

Diagnosis of viral respiratory infections is traditionally performed using conventional methods based on viral culture (VC), or antigen detection such as immunofluorescence assays (IF). VC remains the gold-standard but it requires trained personnel, results may take a few days, and not all viruses can multiply in culture. IF techniques are quick and they allow quality control of samples but they need big expertise for interpretation. Additionally, they are not available for all viruses and lack sensitivity for others [Ginocchio and McAdam, 2011] .

Nucleic acid amplification tests (NAATs) have become an alternative that offers high sensitivity and specificity when compared to conventional methods [Elnifro et al., 2000; Mahony, 2008; Ginocchio and McAdam, 2011] . Numerous tests have been developed using multiplex PCR to detect several viruses, including those that are not detected either by VC or by immunoassays. Although PCR-based techniques were initially limited by the few types of viruses that could be detected in a single test [Liolios et al., 2001; Coiras et al., 2004; Bellau-Pujol et al., 2005; Freymuth et al., 2006] , numerous multiplex PCR tests have been developed, allowing more than 10 viruses to be detected in a single assay. Amplicon detection can be performed by hybridization using microarrays [Henrickson et al., 2007; Raymond et al., 2009; Cannon et al., 2010; Renois et al., 2010; Frobert et al., 2011; Culebras et al., 2013; Pillet et al., 2013] or semiconductor-based DNA microspheres [Mahony et al., 2007] . Several respiratory virus panels (RVP) have been commercialized, such as xTAG 1 RVP from Luminex 1 [Mahony et al., 2007; Pabbaraju et al., 2008; Gadsby et al., 2010; Balada-Llasat et al., 2011; Kim et al., 2013; Pillet et al., 2013] , Multicode PLx RVP from Eragen [Balada-Llasat et al., 2011] , and Resplex 1 II from Qiagen [Li et al., 2007; Balada-Llasat et al., 2011; Pillet et al., 2013] . Other NAATs are the multiplex ligationdependent probe amplification system (MLPA) [Reijans et al., 2008; Bruijnesteijn van Coppenraet et al., 2010; Pillet et al., 2013] and the dual priming oligonucleotide (DPO) system [Roh et al., 2008; Bruijnesteijn van Coppenraet et al., 2010; Zhang et al., 2012; Cho et al., 2013; Kim et al., 2013; Pillet et al., 2013] . PCR-based systems generate a diagnostic result within only one working day, but implementation in a laboratory routine may not be costeffective.

This study assessed two multiplex PCR-based techniques commercially available, namely Clart 1 and Seeplex 1 . Both NAATs have been studied previously [Roh et al., 2008; Bruijnesteijn van Coppenraet et al., 2010; Renois et al., 2010; Frobert et al., 2011; Zhang et al., 2012; Cho et al., 2013; Culebras et al., 2013; Kim et al., 2013; Pillet et al., 2013] and, in the present work, they were compared with each other and also with two conventional methods for the diagnosis of viral respiratory infections. The aim of this work was to discuss the clinical interpretation of the results obtained by NAATs on the basis of our two-decade experience on conventional methods. The benefits and pitfalls of molecular techniques are also discussed.

Eighty nasopharyngeal aspirates were collected from children under six years attended for acute respiratory illness at the pediatric emergency room of a third level Hospital, from October to November 2008 and from February to March 2009. Consecutive specimens, with more than 25 cells/field by microscopic observation and sufficient residual volume (300 mL), were selected. These specimens were processed within the same working day or stored at þ4˚C during the weekends (maximum 72 hr). Epidemiological data were collected.

Samples were assessed using D3 DFA Metapneumovirus Identification Kit (Diagnostics Hybrids, Athens, OH), RSV Direct IF (bioM erieux, Marcyl'Etoile, France), and Respiratory Panel 1 Viral Screening & Identification IFA kit (Millipore, Light Diagnostics, Temecula, CA) to detect AdV, FLUAV, FLUBV, PIV-1,2,3 and RSV according to the manufacturer's instructions. For viral isolation, these samples were cultured using six cell lines: MRC5, A549, HEP2, MDCK, LLCMK2, and RD (Vircell S.L Santa Fe, Granada, Spain). All cell cultures were examined daily for cytopathic effect during two weeks. Definitive identification was assessed by IF.

Nucleic acid was extracted from 200 mL of clinical samples using EZ1 Virus Mini Kit v2.0 and Bio Robot EZ-1 (Qiagen, Hilden, Germany), according to the manufacturer's instructions. The extracts were stored at À80˚C until use. Molecular viral detection was performed using two NAATs: Seeplex 1 RV12 ACE Detection Kit (Seegene, Seoul, South Korea) and Clart 1 Pneumovir Kit (Genomica, Madrid, Spain), following the manufacturer's instructions.

The Seeplex 1 method is based on the DPO system and amplicon detection is performed by fully automated capillary electrophoresis separation (MultiNA, Shimad-zuBiotech, Kyoto, Japan). This method provides results in about six hours. The Clart 1 system is based on microarray technology and analysis of the resulting hybridization pattern is performed using optical equipment (Clondiag Chip Technologies, Jena, Germany). This method provides results in about 9 hr. Both assays detect FLUAV, FLUBV, AdV, hMPV, HCoV-229E, PIV-1, PIV-2, PIV-3, RSVa, RSVb, and RV. Seeplex 1 also detects HCoV-NL63 and HCoV-OC43, and differentiates between species of RV (A and B). Clart 1 also detects HBoV, Influenza C virus (FLUCV), EV, PIV-4 A/B, and differentiates between hMPVa and hMPVb. Both assays included an internal control to detect amplification inhibition. Both NAATs gave qualitative results only.

Epidemiological data, such as age, sex, date of sample collection and clinical diagnosis, were collected. Statistical analyses were performed using the Vassar Stats website (http://vassarstats.net/).

In this work a result was considered clinically relevant or true positive when a respiratory virus was detected by IF and/or VC regardless of NAATs results or by both NAATs (criterion of positivity).

The range of viruses detected differed depending on the virus and the method used (Table I) . Of 80 samples included in this study, viral detection was obtained in 37, 40, and 62 samples by IF/VC, Seeplex 1 and Clart 1 , respectively. Either NAAT yielded a positive result in 40 samples that were negative by IF/VC. Only three samples (4%) were negative by all the techniques assessed (Table I) .

Seeplex 1 and Clart 1 detected 11 and 57 viruses more than IF/VC, respectively. RVs were the viruses most frequently detected by PCR although only two were recovered by IF/VC (Table I) . Multiple detection was obtained in 30 samples by NAATs while IF/VC did not achieve multiple recovery in any case. Inhibition was observed in 19 samples, 10 by Seeplex 1 (12.5%) and 11 by Clart 1 (14%); two of these samples were inhibited by both methods.

According to the established criterion of positivity, 46 (57.5%) samples were considered positive for a respiratory virus; 36 by IF/VC regardless of NAAT results and 10 by two NAATs only. Viral detection was coincident between IF/VC and both NAATs in 20 samples out of 36. Coincident results were found between IF/VC and only one NAAT in 12 samples (one by Seeplex 1 and 11 by Clart 1 ). Three samples had a positive viral detection by IF/VC but were negative by NAATs. Another positive sample was inhibited. In three positive samples by IF/VC, additional viruses were detected by both Seeplex 1 and Clart 1 . RV were detected in all samples positive only by both NAATs (n ¼ 10), one of them having an additional virus (AdV). Overall, 50 significant viruses were detected. Since EVs were only detected by one NAAT, they were not included in further calculations. Considering the remaining significant viruses, the relative sensitivity of IF/VC, Seeplex 1 and Clart 1 was 70% (32/46), 76% (35/46), and 89% (41/46), respectively (Table II) .

NAATs achieved a high rate of multiple virus detection (37.5%; 30/80), corresponding to 10% (8/80) by Seeplex 1 and 31% (25/80) by Clart 1 . Regarding viruses identified only by one technique, Clart 1 detected HBoVs in 16 samples and 13 of them (81%) were multiple detections. Seeplex 1 detected HCoV-OC43 in five samples corresponding to multiple detections in three cases (60%). Following the criterion of positivity previously established, only four samples were considered to have real multiple infections (8.7%; 4/46) (Table III) .

Regarding clinical and demographic analysis, no relevant data were obtained. From the total number of samples assessed, 39 and 41 specimens belonged to patients with upper and lower respiratory tract infections (URTI and LRTI), respectively. The viral distribution did not follow a definite pattern although RSV and AdV were predominantly detected in patients with LRTI and URTI, respectively. No statistically significant association was found between viruses detected and each clinical group.

The main finding in the present study was that both NAATs used to detect respiratory viruses yielded different results. As expected, NAATs detected more viruses than the conventional techniques. The question remains, however, as to whether this extra sensitivity provides more reliable information about the etiology of the infection. Clart 1 had the highest detection rate and results agreed with conventional results more often than those by Seeplex 1 . This could be due to the different range of viruses covered by each technique. Although both NAATs have been investigated before, the methods used as gold standard were different [Roh et al., 2008; Bruijnesteijn van Coppenraet et al., 2010; Frobert et al., 2011; Zhang et al., 2012; Cho et al., 2013; Culebras et al., 2013; Kim et al., 2013; Pillet et al., 2013 ]. An important drawback in comparing NAATs is therefore the lack of a real gold standard.

Both conventional and PCR-based methods yielded similar results for RSV and ADV. For RSV, IF was more sensitive than VC and equally sensitive to the molecular methods. For AdV, isolation in cell cultures is usually required because of the poor sensitivity of IF and the number of AdV isolates coincided with those detected by molecular methods. These findings coincided with the experience of our group over the last two decades and have been reported by other authors [Dunn et al., 2004; Mahony, 2008; Doan et al., 2012; Cho et al., 2013] .

Molecular techniques have been the key to diagnosing a large range of new viruses incapable of multiplying in VC, such as HCoV and HBoV, and the new species of RV. Considering those viruses detected only by PCR, about 72% corresponded to RV, hMPV, HCoV-OC43, PIV-4, FLUCV, and HBoV. As in previous studies, both NAATs largely increased the number of RV detected [Freymuth et al., 2006; Li et al., 2007; Mahony et al., 2007; Bruijnesteijn van Coppenraet et al., 2010; Cho et al., 2013] .

NAATs do not always give a result. Inhibition of the amplification reaction is a drawback, mainly because of the specimen itself or the extraction protocol. Both NAATs tested yielded inhibited results. The fact that most inhibited samples differed between the two techniques, despite the extract being the same, suggests that the methods were probably the main cause of PCR inhibition.

The failure of NAATs to give a result may also be because of the lack of a specific target. This is not only because the target is not included in the reaction, as in the case of Human herpesvirus 5, but also because of the variability of the respiratory viruses. Therefore laboratories, especially those that rely only on NAATs, need to constantly review the viruses included in the assays they use [Ogilvie, 2001] .

NAATs have created a new scenario in the diagnosis of viral respiratory infections: the high yield of multiple viral detections [Kuypers et al., 2006; Madhi and Klugman, 2006; Leland and Ginocchio, 2007] . Compared to Seeplex 1 , the Clart 1 system tripled the number of multiple detections; differences in their design, particularly concerning the primers and the amplification conditions, may contribute to this disparity. The high rate of multiple detection, which may be explained because of the pediatric population, is in agreement with other authors [Roh et al., 2008; Kim et al., 2009; Bruijnesteijn van Coppenraet et al., 2010; Frobert et al., 2011; Zhang et al., 2012] .

So an important remaining question is the clinical relevance of the results obtained by NAATs. Covering a broad range of etiological agents, these quick techniques may be especially useful in immunosupressed or critically ill patients although their clinical impact is not yet well established [Garbino et al., 2009; Schnell et al., 2012] . However, as NAATs detect viral nucleic acids regardless of the presence of viral antigens or infective viruses [Pagarolas and Sune, [Elnifro et al., 2000; Mahony, 2008; Ginocchio and McAdam, 2011; Jansen et al., 2011] . Although the viral load may be useful to predict the correlation of a virus and an infectious process it is not well-established for respiratory viral infections [Kuypers et al., 2006; Debiaggi et al., 2012] . The prevalence of specific viruses based on NAATs differs between symptomatic and asymptomatic children [Debiaggi et al., 2012; Buller, 2013] . Some viruses, such as RSV, are usually associated with clinical illness and should be considered as the etiological agent in a patient with respiratory symptoms. In contrast, viruses such as RV, HCoV, and HBoV seem to be frequently found in asymptomatic children [Debiaggi et al., 2012; Meriluoto et al., 2012] although more studies on this issue are required.

The management of patients requires reporting results within a clinically relevant time-scale; microbiology laboratories should take this into consideration when choosing a diagnostic test. NAATs are faster than culture, which requires two days minimum; both NAATs tested had a turn around time of six and nine hours. However, most NAATs are not faster than IF or immunochromatography. Rapid antigen detection tests of certain respiratory viruses provide a result with very high specificity within 15-30 min [Mandell et al., 2007] . In the epidemic situation, the use of these techniques as the first step to detect viruses such as influenza virus or RSV may accelerate results and bring simplicity to the laboratory. Only the negative results would require further analysis [Buller, 2013] . Another important point is that NAATs and antigen detection techniques only detect the specific viruses under investigation; other viruses that may be related to the clinical process will not be detected.

The combination of several methods in the diagnosis of viral respiratory infections is still a great option. However, not all laboratories have the facilities or the personnel required to perform a wide range of techniques, such as antigen detection tests, virus isolation and molecular tests. NAATs are particularly useful in detecting new viruses and in giving a quick result. However, the interpretation of a molecular test is not always straightforward. The clinical virologist must consider the pros and cons of the technique used and the clinical impact of the result.

Evaluation of commercial ResPlex II v2.0, MultiCode-PLx, and xTAG respiratory viral panels for the diagnosis of respiratory viral infections in adults

Development of three multiplex RT-PCR assays for the detection of 12 respiratory RNA viruses

Comparison of two commercial molecular assays for simultaneous detection of respiratory viruses in clinical samples using two automatic electrophoresis detection systems

Molecular detection of respiratory viruses

Multiplex PCR and emerging technologies for the detection of respiratory pathogens

A low density oligonucleotide microarray for the detection of viral and atypical bacterial respiratory pathogens

Simultaneous detection of fourteen respiratory viruses in clinical specimens by two multiplex reverse transcription nested-PCR assays

Detection and genotyping of human respiratory viruses in clinical specimens from children with acute respiratory tract infections

Evaluation of a novel real-time RT-PCR using TOCE technology compared with culture and Seeplex RV15 for simultaneous detection of respiratory viruses

The role of infections and coinfections with newly identified and emerging respiratory viruses in children

Rapid viral diagnosis for acute febrile respiratory illness in children in the Emergency Department

Sensitivity of respiratory virus culture when screening with R-mix fresh cells

Multiplex PCR: Optimization and application in diagnostic virology

Comparison of multiplex PCR assays and conventional techniques for the diagnostic of respiratory virus infections in children admitted to hospital with an acute respiratory illness

Respiratory viruses in children admitted to hospital intensive care units: Evaluating the CLART(R) Pneumovir DNA array

Comparison of the Luminex Respiratory Virus Panel fast assay with in-house real-time PCR for respiratory viral infection diagnosis

Respiratory viruses in bronchoalveolar lavage: A hospital-based cohort study in adults

Current best practices for respiratory virus testing

Comparison of electronic microarray to enzyme hybridization assay for multiplex reverse-transcriptase PCR detection of common respiratory viruses in children

Frequent detection of respiratory viruses without symptoms: Toward defining clinically relevant cutoff values

Comparison of Anyplex II RV16 with the xTAG respiratory viral panel and Seeplex RV15 for detection of respiratory viruses

Rapid detection and identification of 12 respiratory viruses using a dual priming oligonucleotide system-based multiplex PCR assay

Comparison of real-time PCR assays with fluorescent-antibody assays for diagnosis of respiratory virus infections in children

Role of cell culture for virus detection in the age of technology

Simultaneous detection and high-throughput identification of a panel of RNA viruses causing respiratory tract infections

Comparison of a multiplex reverse transcription-PCR-enzyme hybridization assay with conventional viral culture and immunofluorescence techniques for the detection of seven viral respiratory pathogens

Acute Respiratory Infections

Development of a respiratory virus panel test for detection of twenty human respiratory viruses by use of multiplex PCR and a fluid microbead-based assay

Detection of respiratory viruses by molecular methods

Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults

Association of human bocavirus 1 infection with respiratory disease in childhood follow-up study

Molecular techniques should not now replace cell culture in diagnostic virology laboratories

Comparison of the Luminex xTAG respiratory viral panel with in-house nucleic acid amplification tests for diagnosis of respiratory virus infections

Microbiological diagnosis of viral respiratory infections in the adult patient

Comparative evaluation of six commercialized multiplex PCR kits for the diagnosis of respiratory infections

Comparison of automated microarray detection with real-time PCR assays for detection of respiratory viruses in specimens obtained from children

RespiFinder: A new multiparameter test to differentially identify fifteen respiratory viruses

Rapid detection of respiratory tract viral infections and coinfections in patients with influenzalike illnesses by use of reverse transcription-PCR DNA microarray systems

Comparison of the Seeplex reverse transcription PCR assay with the R-mix viral culture and immunofluorescence techniques for detection of eight respiratory viruses

Molecular detection of respiratory viruses in immunocopromised ICU patients: Incidence and meaning

Increased detection of respiratory syncytial virus, influenza viruses, parainfluenza viruses, and adenoviruses with real-time PCR in samples from patients with respiratory symptoms

High incidence of multiple viral infections identified in upper respiratory tract infected children under three years of age in Shanghai

The authors would like to thank Dr. Adela Retana for clinical data review, and Margarita del Cuerpo, and Oscar Cordon for their technical assistance. Kits for molecular detection of viruses were kindly provided by Genomica S.A.U. and Izasa-Werfen Group.